Figures computed from official regulatory filings — .
Analysttarget 33.56 USD (+658%)
Ownershipinsiders 38.21% · institutions 1.03% · short 0.0% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Intercure Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Market information source · Oct 19, 2026
SEC company identity · Oct 19, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Cohen Amos | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |